N/A
Completed N=321
A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
Source: ClinicalTrials.gov NCT00253019 ↗Enrolled (actual)
321
Serious AEs
0.0%
Results posted
Aug 2013
Primary outcomePrimary: Continuation Rates — 82; 78; 83 participants
Summary
This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Continuation Rates |
82; 78; 83 | — |
Eligibility Criteria
Inclusion Criteria
- Age 13-45 women presenting at the ambulatory surgery at Grady Memorial Hospital who want to use either oral contraceptive pills, ortho evra or depo provera?
Exclusion Criteria
- Leaving the Atlanta area within 6 months?
- Desires pregnancy within the next 6 months?
- Unable to provide contact information?
- Contraindications to hormonal contraceptive?
Data sourced from ClinicalTrials.gov (NCT00253019). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.